pGM169/GL67A

DRUG2 trials

Sponsors

Imperial College London

Conditions

Cystic Fibrosis

Phase 1

Single Dose of pGM169/GL67A in CF Patients

CompletedNCT00789867

Imperial College LondonCystic Fibrosis

Start: 2008-11-30End: 2010-12-31Updated: 2020-01-18

Phase 2

Repeated Application of Gene Therapy in CF Patients

CompletedNCT01621867

Imperial College LondonCystic Fibrosis

Start: 2012-05-31End: 2014-05-31Updated: 2015-10-22

Related Papers

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

Efficacy and Mechanism Evaluation2016-07-0145 citations

A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial

American Journal of Respiratory and Critical Care Medicine2015-12-0153 citations

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.

2015-07-03290 citations

P204 Immune Responses To Single And Repeated Administration Of Pgm169/gl67a: The Uk Cf Gene Therapy Consortium Clinical Trials

Thorax2014-11-10